These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Corticotropin releasing factor receptor antagonists for major depressive disorder. Paez-Pereda M; Hausch F; Holsboer F Expert Opin Investig Drugs; 2011 Apr; 20(4):519-35. PubMed ID: 21395482 [TBL] [Abstract][Full Text] [Related]
4. Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments. Tellew JE; Luo Z Curr Top Med Chem; 2008; 8(6):506-20. PubMed ID: 18397172 [TBL] [Abstract][Full Text] [Related]
5. Structure and Function of Small Non-Peptide CRF Antagonists and their Potential Clinical Use. Fahmy H; Kuppast B; Ismail MT Curr Mol Pharmacol; 2017; 10(4):270-281. PubMed ID: 27809751 [TBL] [Abstract][Full Text] [Related]
6. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors. Hummel M; Cummons T; Lu P; Mark L; Harrison JE; Kennedy JD; Whiteside GT Neuropharmacology; 2010 Sep; 59(3):160-6. PubMed ID: 20470804 [TBL] [Abstract][Full Text] [Related]
8. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems. Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonists. Hartz RA; Nanda KK; Ingalls CL; Ahuja VT; Molski TF; Zhang G; Wong H; Peng Y; Kelley M; Lodge NJ; Zaczek R; Gilligan PJ; Trainor GL J Med Chem; 2004 Sep; 47(19):4741-54. PubMed ID: 15341489 [TBL] [Abstract][Full Text] [Related]
10. Development of CRF1 receptor antagonists as antidepressants and anxiolytics: progress to date. Valdez GR CNS Drugs; 2006; 20(11):887-96. PubMed ID: 17044726 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and structure-activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF₁ receptor antagonists. Takeda K; Terauchi T; Hashizume M; Shin K; Ino M; Shibata H; Yonaga M Bioorg Med Chem Lett; 2012 Sep; 22(17):5372-8. PubMed ID: 22871582 [TBL] [Abstract][Full Text] [Related]
12. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Taché Y; Martinez V; Million M; Maillot C Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197 [TBL] [Abstract][Full Text] [Related]
13. Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders. Kehne J; De Lombaert S Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):467-93. PubMed ID: 12769601 [TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design. Ye Y; Liao Q; Wei J; Gao Q Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115 [TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants? Nielsen DM Life Sci; 2006 Jan; 78(9):909-19. PubMed ID: 16122764 [TBL] [Abstract][Full Text] [Related]
16. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Gravanis A; Margioris AN Curr Med Chem; 2005; 12(13):1503-12. PubMed ID: 15974983 [TBL] [Abstract][Full Text] [Related]
17. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain. Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757 [TBL] [Abstract][Full Text] [Related]
18. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236 [TBL] [Abstract][Full Text] [Related]